Liraglutide Subcutaneous and Orphenadrine Extended-Release Tablets
Determining the interaction of Liraglutide Subcutaneous and Orphenadrine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: liraglutide
Brand name: Saxenda, Victoza
Synonyms: Liraglutide
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Liraglutide Subcutaneous-Orphenadrine Injection
- Liraglutide Subcutaneous-Orphenadrine w/A.C.
- Liraglutide Subcutaneous-Orphenadrine, aspirin, and caffeine
- Liraglutide Subcutaneous-Orphenate
- Liraglutide Subcutaneous-Orphengesic
- Liraglutide Subcutaneous-Orphengesic Forte
- Orphenadrine Extended-Release Tablets-Lisdexamfetamine
- Orphenadrine Extended-Release Tablets-Lisdexamfetamine Capsules
- Orphenadrine Extended-Release Tablets-Lisdexamfetamine Chewable Tablets
- Orphenadrine Extended-Release Tablets-Lisdexamfetamine dimesylate
- Orphenadrine Extended-Release Tablets-Lisinopril
- Orphenadrine Extended-Release Tablets-Lisinopril and Hydrochlorothiazide